Back
Cogent Biosciences, Inc. 10K Form
Buy
57
COGT
Cogent Biosciences, Inc.
Last Price:
$39.34
Seasonality Move:
-22.63%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-10 | 10Q | COGT/Cogent Biosciences, Inc. Quarterly |
| 2020-05-11 | 10Q | COGT/Cogent Biosciences, Inc. Quarterly |
| 2020-03-13 | 10K | COGT/Cogent Biosciences, Inc. Annual |
| 2019-11-12 | 10Q | COGT/Cogent Biosciences, Inc. Quarterly |
| 2019-08-09 | 10Q | COGT/Cogent Biosciences, Inc. Quarterly |
| 2019-05-10 | 10Q | COGT/Cogent Biosciences, Inc. Quarterly |
Receive COGT News And Ratings
See the #1 stock for the next 7 days that we like better than COGT
COGT Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-64.4M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $1.39 |
| Price / Book: | 30.9 |
Profitability
| EPS (TTM): | -2.37060 |
|---|---|
| Net Income (TTM): | $-294.4M |
| Gross Margin: | $-4.4M |
| Return on Equity: | -117.99% |
| Return on Assets: | -86.76% |
Cogent Biosciences, Inc. Earnings Forecast
Key Cogent Biosciences, Inc. Financial Ratios
-
Per Share Earnings over the last 12 years have been positive in 3 years.
Cogent Biosciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | COGT |
| CUSIP: | 19240Q |
| Website: | cogentbio.com |
Debt
| Debt-to-Equity Ratio: | 0.2 |
|---|---|
| Current Ratio: | 6.38 |
| Quick Ratio: | 6.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
COGT Technical Analysis vs Fundamental Analysis
Buy
57
Cogent Biosciences, Inc. (COGT)
is a Buy
Is Cogent Biosciences, Inc. a Buy or a Sell?
-
Cogent Biosciences, Inc. stock is rated a BuyThe current Cogent Biosciences, Inc. [COGT] share price is $39.16. The Score for COGT is 57, which is 14% above its historic median score of 50, and infers lower risk than normal.